Back to Authors

Xu, Yinyan

https://orcid.org/0000-0001-7960-8278

A5009684011 | I47396830

Mayo Clinic

Hematology/Oncology Celgene Corporation Shanghai China

Citations 1

ROBUST: PHASE III RANDOMIZED STUDY OF LENALIDOMIDE/R‐CHOP VS PLACEBO/R‐CHOP IN UNTREATED ABC‐TYPE DIFFUSE LARGE B‐CELL LYMPHOMA AND FEASIBILITY OF CELL OF ORIGIN SUBTYPING

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 419-419

10.1002/hon.2440